Challenges and considerations of genetic testing in von Willebrand disease by Omid Seidizadeh, Luciano Baronciani, Flora Peyvandi

Get full text

Impact of blood centrifugation on the parameters of thrombin generation assay revisited to look for possible revision of the current guidance by Erica Scalambrino, Marigrazia Clerici, Flora Peyvandi, Armando Tripodi

Get full text

Global estimation of the bleeding episodes treatable with desmopressin in von Willebrand disease and hemophilia A by Alessandro Gringeri, Pier Mannuccio Mannucci, Michele Gringeri, Giancarlo Castaman, Flora Peyvandi

Get full text

Hypercoagulability Is a Stronger Risk Factor for Ischaemic Stroke than for Myocardial Infarction: A Systematic Review. by Alberto Maino, Frits R Rosendaal, Ale Algra, Flora Peyvandi, Bob Siegerink

Get full text

Genetic determinants of clinical variability in type 2 von Willebrand disease: bridging genotype and phenotype by Omid Seidizadeh, Alessandro Ciavarella, Luciano Baronciani, Paola Colpani, Andrea Cairo, Simona Maria Siboni, Flora Peyvandi

Get full text

Comparative Investigation of Thromboelastometry and Thrombin Generation for Patients Receiving Direct Oral Anticoagulants or Vitamin K Antagonists by Armando Tripodi, Marco Capecchi, Erica Scalambrino, Marigrazia Clerici, Barbara Scimeca, Pasquale Agosti, Paolo Bucciarelli, Andrea Artoni, Flora Peyvandi

Get full text

A-SURE: intra-patient comparison of prophylactic effectiveness of a recombinant factor VIII Fc fusion protein versus standard half-life factor VIII in hemophilia A by Johannes Oldenburg, Charles Hay, Flora Peyvandi, Anna-Elina Lehtinen, Ingrid Pabinger, Eveline Nüesch, Håkan Malmström, Eva Bednar, Stefan Lethagen

Get full text

Inhibitor development in nonsevere hemophilia: data from the European Haemophilia Safety Surveillance (EUHASS) registry by Kathelijn Fischer, Riitta Lassila, Flora Peyvandi, Alexander Gatt, Samantha C. Gouw, Robert Hollingsworth, Thierry Lambert, Radek Kaczmarek, Diana Carbonero Alvarez, Michael Makris

Get full text

Procoagulatory State in Inflammatory Bowel Diseases Is Promoted by Impaired Intestinal Barrier Function by Luca Pastorelli, Elena Dozio, Laura Francesca Pisani, Massimo Boscolo-Anzoletti, Elena Vianello, Nadia Munizio, Luisa Spina, Gian Eugenio Tontini, Flora Peyvandi, Massimiliano Marco Corsi Romanelli, Maurizio Vecchi

Get full text

Preoperative Hematocrit Concentration and the Risk of Stroke in Patients Undergoing Isolated Coronary-Artery Bypass Grafting by Khaled M. Musallam, Faek R. Jamali, Frits R. Rosendaal, Toby Richards, Donat R. Spahn, Kaivan Khavandi, Iskandar Barakat, Benjamin Demoss, Luca A. Lotta, Flora Peyvandi, Pier M. Sfeir

Get full text

Marginal zone lymphoma with anti-factor H IgM and atypical hemolytic uremic syndrome successfully treated with odronextamab by Gianluigi Ardissino, Piera Angelillo, Maria Cristina Mancuso, Samantha Griffini, Elena Grovetti, Luigi Porcaro, Thomas Ria, Sarah Marktel, Flora Peyvandi, Stefano Luminari, Andrés J.M. Ferreri, Michele Merli, Massimo Cugno

Get full text

Adeno-associated virus-based gene therapy for hemophilia–addressing the gaps by Wolfgang Miesbach, Paul Batty, Pratima Chowdary, Sylvia Fong, Radoslaw Kaczmarek, Frank W.G. Leebeek, Brian Long, Johnny Mahlangu, Mike Makris, Glenn F. Pierce, Steven W. Pipe, Alok Srivastava, Jan Voorberg, Flora Peyvandi

Get full text

The usefulness of D-dimer as a predictive marker for mortality in patients with COVID-19 hospitalized during the first wave in Italy. by Shermarke Hassan, Barbara Ferrari, Raffaella Rossio, Vincenzo la Mura, Andrea Artoni, Roberta Gualtierotti, Ida Martinelli, Alessandro Nobili, Alessandra Bandera, Andrea Gori, Francesco Blasi, Valter Monzani, Giorgio Costantino, Sergio Harari, Frits Richard Rosendaal, Flora Peyvandi, COVID-19 Network working group

Get full text

Gynecologic and obstetric complications in women with congenital fibrinogen disorders: insights from the Prospective Rare Bleeding Disorders Database by Samin Mohsenian, Roberta Palla, Marzia Menegatti, Andrea Cairo, Simona Maria Siboni, Marguerite Neerman-Arbez, Mehran Karimi, Helen Pargantou, Rosanna Asselta, Danijela Mikovic, Marko Saracevic, Britta Laros-van Gorkom, Laura Jacobs, Amy Shapiro, Adrianna Williamson, Michael Makris, Alessandro Casini, Flora Peyvandi

Get full text

Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study by Syna Miri, Frits R. Rosendaal, Kaan Kavakli, Peyman Eshghi, Soha Mohammadi Moghaddam, Sara Scardo, Behnaz Habibpanah, Mohsen Elalfy, Susan Halimeh, Gabriella Nicolò, Dilek Gökçebay, Namık Özbek, Tiraje Celkan, Ahmad Mohammadi, Mehran Karimi, Amin Shahsavani, Bariş Yılmaz, Canan Albayrak, Burcak Gunes, Zühre Kaya, Yilmaz Ay, Sinan Akbayram, Nazan Sarper, Pier Mannuccio Mannucci, Flora Peyvandi

Get full text

Efficacy, safety, and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr8-1 trial by Andrew D. Leavitt, Johnny Mahlangu, Priyanka Raheja, Emily Symington, Doris V. Quon, Adam Giermasz, Maria Fernanda López Fernández, Gili Kenet, Gillian Lowe, Nigel S. Key, Carolyn M. Millar, Steven W. Pipe, Bella Madan, Sheng-Chieh Chou, Robert Klamroth, Jane Mason, Hervé Chambost, Flora Peyvandi, Elaine Majerus, Dominic Pepperell, Christine Rivat, Hua Yu, Tara M. Robinson, Margareth C. Ozelo

Get full text

Effect of DNA methylation on inhibitor development in people with hemophilia A treated with FVIII concentrates by Himani Chand, Shermarke Hassan, Andrea Cairo, Roberta Palla, Flora Peyvandi, Flora Peyvandi, Pier M. Mannucci, Isabella Garagiola, Amal El-Beshlawy, Mohsen Elalfy, Vijay Ramanan, Peyman Eshghi, Suresh Hanagavadi, Ramabadran Varadarajan, Mehran Karimi, Mamta V. Manglani, Cecil Ross, Guy Young, Tulika Seth, Shashikant Apte, Dinesh M. Nayak, Elena Santagostino, Maria Elisa Mancuso, Adriana C. Sandoval Gonzalez, Johnny N. Mahlangu, Santiago Bonanad Boix, Monica Cerqueira, Nadia P. Ewing, Christoph Male, Tarek Owaidah, Veronica Soto Arellano, Nathan L. Kobrinsky, Suvankar Majumdar, Rosario Perez Garrido, Anupam Sachdeva, Mindy Simpson, Mathew Thomas, Ezio Zanon, Bulent Antmen, Kaan Kavakli, Marilyn J. Manco-Johnson, Monica Martinez, Esperanza Marzouka, Maria G. Mazzucconi, Daniela Neme, Angeles Palomo Bravo, Rogelio Paredes Aguilera, Alessandra Prezotti, Klaus Schmitt, Brian M. Wicklund, Bulent Zulfikar, Frits R. Rosendaal

Get full text

Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)Research in context by Paul Coppo, Michael Bubenheim, Ygal Benhamou, Linus Völker, Paul Brinkkötter, Lucas Kühne, Paul Knöbl, Maria Eva Mingot-Castellano, Cristina Pascual-Izquierdo, Javier de la Rubia, Julio del Rio Garma, Shruti Chaturvedi, Camila Masias, Marshall Mazepa, X. Long Zheng, György Sinkovits, Marienn Réti, Christopher J. Patriquin, Katerina Pavenski, Tiago Boechat, João Farias, Eduardo Flavio Oliveira Ribeiro, Michaela Larissa Lobo de Andrade, Agnès Veyradier, Bérangère Joly, Raïda Bouzid, Kazuya Sakai, Masanori Matsumoto, Pasquale Agosti, Ilaria Mancini, Flora Peyvandi, Eleni Gavriilaki, Matthew Stubbs, Amjad Hmaid, Spero Cataland, Bernhard Lämmle, Marie Scully

Get full text